Detalles de la búsqueda
1.
Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma.
Eur J Nucl Med Mol Imaging
; 49(4): 1187-1199, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651229
2.
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 716-726, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857411
3.
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
Eur Radiol
; 31(7): 4764-4773, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33399908
4.
Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy.
Sci Rep
; 14(1): 1768, 2024 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242940
5.
Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease.
RMD Open
; 10(2)2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663883
6.
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Nat Commun
; 15(1): 1029, 2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310101
7.
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
BMJ
; 385: e077890, 2024 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38897625
8.
Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor.
Front Immunol
; 14: 1069010, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733479
9.
Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma.
Front Immunol
; 14: 1124066, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860875
10.
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593221
11.
Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma.
Front Oncol
; 12: 860700, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756638
12.
Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary.
J Cancer Res Clin Oncol
; 148(8): 1931-1942, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486182
13.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 553-561, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175316
14.
Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease.
Front Immunol
; 13: 978708, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36211445
15.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(5): 706-714, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323856
16.
Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy.
J Inflamm Res
; 14: 2225-2237, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079329
17.
Trajectories of EBV DNA and identifying the potential long-term survivors in metastatic nasopharyngeal carcinoma.
Am J Cancer Res
; 11(8): 3946-3955, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34522460
18.
Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta-Analysis.
Front Oncol
; 11: 650292, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33968750
19.
Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival.
Biol Sex Differ
; 12(1): 18, 2021 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516267
20.
A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma.
J Inflamm Res
; 14: 817-828, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33732007